The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The ubiquitin–proteasome system and skeletal muscle wasting
Abstract
The ubiquitin–proteasome system (UPS) is believed to degrade the major contractile skeletal muscle proteins and plays a major role in muscle wasting. Different and multiple events in the ubiquitination, deubiquitination and proteolytic machineries are responsible for the activation of the system and subsequent muscle wasting. However, other proteolytic enzymes act upstream (possibly m-calpain, cathepsin L, and/or caspase 3) and downstream (tripeptidyl-peptidase II and aminopeptidases) of the UPS, for the complete breakdown of the myofibrillar proteins into free amino acids. Recent studies have identified a few critical proteins that seem necessary for muscle wasting {i.e. the MAFbx (muscle atrophy F-box protein, also called atrogin-1) and MuRF-1 [muscle-specific RING (really interesting new gene) finger 1] ubiquitin–protein ligases}. The characterization of their signalling pathways is leading to new pharmacological approaches that can be useful to block or partially prevent muscle wasting in human patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539
IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., Hasselgren, P.-O., Frontera, W. R., Lee, J., Glass, D. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.027 · Cited by 1,367
The Molecular Basis of Skeletal Muscle Atrophy
Jackman, R. W., & Kandarian, S. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00579.2003 · Cited by 1,008 · cited 2×
“Major advances have been made in the elucidation of signalling pathways that regulate the UPS in muscle (see [24] for a recent detailed review).”
Du, J., Wang, X., Miereles, C., Bailey, J. L., Debigare, R., Zheng, B., Price, S. R., & Mitch, W. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18330 · Cited by 731
Li, H.-H., Kedar, V., Zhang, C., McDonough, H., Arya, R., Wang, D.-Z., & Patterson, C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422220 · Cited by 430
Degradation of MyoD Mediated by the SCF (MAFbx) Ubiquitin Ligase
Tintignac, L. A., Lagirand, J., Batonnet, S., Sirri, V., Leibovitch, M. P., & Leibovitch, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411346200 · Cited by 405
What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
Jagoe, R. T., & Goldberg, A. L. (2001) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200105000-00003 · Cited by 399
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I
Kedar, V., McDonough, H., Arya, R., Li, H.-H., Rockman, H. A., & Patterson, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404341102 · Cited by 347
Witt, S. H., Granzier, H., Witt, C. C., & Labeit, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.05.021 · Cited by 310
Tiao, G., Fagan, J. M., Samuels, N., James, J. H., Hudson, K., Lieberman, M., Fischer, J. E., & Hasselgren, P. O. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117588 · Cited by 255
Deval, C., Mordier, S. B., Obled, C., Béchet, D., Combaret, L., Attaix, D., & Ferrara, M. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600143 · Cited by 184
Self-citationSolomon, V., Baracos, V. E., Sarraf, P., & Goldberg, A. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12602 · Cited by 153
USP19 is a ubiquitin-specific protease regulated in rat skeletal muscle during catabolic states
Combaret, L., Adegoke, O. A. J., Bedard, N., Baracos, V. E., Attaix, D., & Wing, S. S. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00281.2004 · Cited by 105
Self-citationCombaret, L., Taillandier, D., Dardevet, D. P., Béchet, D., Rallière, C., Claustre, A., Grizard, J., & Attaix, D. (2004) · Biochemical Journal · doi:10.1042/bj20031660 · Cited by 77
Self-citationCombaret, L., Tilignac, T., Claustre, A., Voisin, L., Taillandier, D., Obled, C., TANAKA, K., & Attaix, D. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610185 · Cited by 76
Self-citationRegulation of proteolysis during reloading of the unweighted soleus muscle
Taillandier, D., AUROUSSEAU, E., Combaret, L., Guézennec, C.-Y., & Attaix, D. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00004-9 · Cited by 71
Self-citationPrice, S. R. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00385-0 · Cited by 57
Control of ubiquitination in skeletal muscle wasting
Wing, S. S. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.11.011 · Cited by 42
Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
Tilignac, T., Temparis, S., Combaret, L., et al. (2002) · PubMed · Cited by 35
Self-citationMechanisms of ubiquitination and proteasome-dependent proteolysis in skeletal muscle.
Attaix, D., Combaret, L., Kee, A. J., & Taillandier, D. (2003) · CABI Publishing eBooks · doi:10.1079/9780851996790.0219 · Cited by 23
Self-citationProteasomes are tightly associated to myofibrils in mature skeletal muscle
Bassaglia, Y., Cebrian, J., Covan, S., Garcia, M. P., & Foucrier, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.038 · Cited by 13
The ubiquitin-proteasome pathway: limitations and opportunities.
Attaix, D., Ventadour, S., Taillandier, D., & Combaret, L. (2005) · PubMed · Cited by 9
Self-citation
Research works printed but not linked: 2
- Farout, 2000, Distribution of proteasomes and of the five proteolytic activities in rat tissues, Arch. Biochem. Biophys., 374, 207, 10.1006/abbi.1999.1585 · doi:10.1006/abbi.1999.1585
- Tilignac, 2002, Erratum. Cancer Res., 62, 7133
Cited by
Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy
Yoshida, T., & Delafontaine, P. (2020) · Cells · doi:10.3390/cells9091970 · Cited by 714
Targeting Proteins for Destruction by the Ubiquitin System: Implications for Human Pathobiology
Schwartz, A. L., & Ciechanover, A. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.051208.165340 · Cited by 492
Boron Containing Compounds as Protease Inhibitors
Smoum, R., Rubinstein, A., Dembitsky, V. M., & Srebnik, M. (2012) · Chemical Reviews · doi:10.1021/cr608202m · Cited by 450
Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases
Moresi, V., Williams, A. H., Meadows, E., Flynn, J. M., Potthoff, M. J., McAnally, J., Shelton, J. M., Backs, J., Klein, W. H., Richardson, J. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.004 · Cited by 444
Mechanisms Regulating Neuromuscular Junction Development and Function and Causes of Muscle Wasting
Tintignac, L. A., Brenner, H.-R., & Rüegg, M. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00033.2014 · Cited by 422
Metadata
- Authors
- Attaix, D., Ventadour, S., Codran, A., Béchet, D., Taillandier, D., & Combaret, L.
- Venue
- Essays in Biochemistry
- Publisher
- Portland Press Ltd.
- Published
- 2005-10-01
- Volume
- 41
- Issue
- 1
- Pages
- 173-186
- ISSN
- 0071-1365 (ISSN-L)
- 1744-1358
- OpenAlex
- W2071088250
- Cited by
- 253
- References
- 24
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.